Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Greenberg, MD
Forest Research Institute, a subsidiary of Forest Laboratories, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Forest Investigative Site 005
Encino, California, United States
- Forest Investigative Site 017
Garden Grove, California, United States
- Forest Investigative Site 027
National City, California, United States
- Forest Investigative Site 013
Newport Beach, California, United States
- Forest Investigative Site 010
Oceanside, California, United States
- Forest Investigative Site 020
Bradenton, Florida, United States
- Forest Investigative Site 007
Jacksonville, Florida, United States
- Forest Investigative Site 019
Kissimmee, Florida, United States
- Forest Investigative Site 026
Orlando, Florida, United States
- Forest Investigative Site 012
West Palm Beach, Florida, United States
- Forest Investigative Site 024
Glen Burnie, Maryland, United States
- Forest Investigative Site 029
Creve Coeur, Missouri, United States
- Forest Investigative Site 002
Omaha, Nebraska, United States
- Forest Investigative Site 028
Cherry Hill, New Jersey, United States
- Forest Investigative Site 001
The Bronx, New York, United States
- Forest Investigative Site 018
Durham, North Carolina, United States
- Forest Investigative Site 004
Dayton, Ohio, United States
- Forest Investigative Site 022
Mason, Ohio, United States
- Forest Investigative Site 015
Portland, Oregon, United States
- Forest Investigative Site 006
Media, Pennsylvania, United States
- Forest Investigative Site 011
Philadelphia, Pennsylvania, United States
- Forest Investigative Site 014
Nashville, Tennessee, United States
- Forest Investigative Site 023
Irving, Texas, United States
- Forest Investigative Site 003
Woodstock, Vermont, United States
- Forest Investigative Site 009
Bellevue, Washington, United States
- Forest Investigative Site 016
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 15 Jun 2010
- Completion
- 15 Jun 2010
- Last update posted
- 23 Aug 2018
- Registered enrollment
- 234
- Registry id
- NCT00852202
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.